Health | Science | Technology | Space | Sports | Entertainment | Mobile | Games | Economy | Politics | Movies | Music | [Top News]

Posts tagged: receives

Boston researcher, surgical oncologist receives national award

May 15, 2012
(Boston) Boston resident Maureen T. Kavanah, MD, an Associate Professor of Surgery at Boston University School of Medicine (BUSM) and a surgical oncologist at Boston Medical Center (BMC), has received the prestigious 2012 National Surgical Adjuvant Breast and Bowel Project (NSABP) Distinguished Investigator Lifetime Achievement Award for her extraordinary ...

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

May 15, 2012
Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine has secured new patents in Europe and the USA relating to Hepatitis C (HCV) drug resistance as it continues to expand its intellectual property portfolio in infectious disease testing.

Harvard cardiologist receives Cedars-Sinai’s Corday Prize in Heart Research

May 15, 2012
Cedars-Sinai Heart Institute is honoring Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine at Harvard Medical School, with The Eliot Corday, MD, International Prize in Heart Research. The Corday Prize has been established to recognize physicians and scientists conducting groundbreaking research that has, or very likely will, change the practice ...

Boston researcher, surgical oncologist receives national award

May 15, 2012
(Boston University Medical Center) Boston resident Maureen T. Kavanah, M.D., an associate professor of surgery at Boston University School of Medicine and a surgical oncologist at Boston Medical Center, has received the prestigious 2012 National Surgical Adjuvant Breast and Bowel Project Distinguished Investigator Lifetime Achievement Award for her extraordinary contributions ...

LA BioMed receives Grand Challenges Explorations grant

May 15, 2012
(Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)) The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill and Melinda Gates Foundation. Frans J. Walther, M.D., Ph.D., FAAP, LA BioMed ...

Washington University receives $8 million to lead international childhood malnutrition effort

May 14, 2012
Jeffrey I. Gordon, MD, at Washington University School of Medicine in St. Louis, will lead an international team of scientists to find new ways to diagnose, treat and prevent a critical global health problem: malnutrition in infants and children. The work is funded by an $8.3 million grant from the ...

Washington University receives $8 million to lead international childhood malnutrition effort

May 14, 2012
(Washington University School of Medicine) Jeffrey I. Gordon, M.D., at Washington University School of Medicine in St. Louis, will lead an international team of scientists to find new ways to diagnose, treat and prevent a critical global health problem: malnutrition in infants and children. The work is funded by an ...

HIV Prevention Pill Receives FDA Panel Support

May 11, 2012
On Thursday, a panel of outside experts that advises the US Food and Drug Administration (FDA) voted to support approval of the daily pill Truvada to prevent HIV in healthy people. The FDA is not obliged to follow the advice of its Antiviral Drugs Advisory Committee, but ...

CTI receives EU conditional marketing authorization for Pixuvri to treat non-Hodgkin B-cell lymphomas

May 11, 2012
CellTherapeutics today announced that it has received conditional marketing authorization from the European Commission for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas. Pixuvri is the first approved treatment in the European Union in this patient setting.

HIV prevention drug receives FDA panel’s backing

May 11, 2012
The drug has already been approved as a treatment for HIV/AIDS. The FDA is expected to decide about approval by June 15.

Trovagene receives European patent titled, ‘Methods for Detection of Nucleic Acid Sequences in Urine’

May 11, 2012
Trovagene, Inc., a developer of trans-renal molecular diagnostics, announced it has received notice of issuance of European Patent No. 2216416 entitled "Methods for Detection of Nucleic Acid Sequences in Urine."

BIOTRONIK receives FDA approval for new Lumax 740 ICDs and CRT devices

May 11, 2012
BIOTRONIK, a leading manufacturer of innovative medical technology, has received FDA approval of its new Lumax 740 implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds). Lumax 740 helps physicians monitor and treat their patients' arrhythmias and heart failure under ever-changing medical conditions.